flufenamic acid has been researched along with sorafenib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Duan, XC; Feng, ZH; Guo, Y; Li, H; Li, ZY; Liao, A; Liu, M; Wang, GX; Wang, JR; Wang, SM; Xu, MQ; Yin, YF; Zhang, S; Zhang, SQ; Zhang, X | 1 |
1 other study(ies) available for flufenamic acid and sorafenib
Article | Year |
---|---|
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.
Topics: 20-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Dinoprostone; Female; Flufenamic Acid; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Silicon Dioxide; Sorafenib; Xenograft Model Antitumor Assays | 2020 |